Fig. 4From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapyCorrelation of anti-Spike IgG, IgA and NAb in IS and INF groups (IS: Immunosuppressive group, INF: Infection group, NAb: Neutralizing antibody)Back to article page